RxDoctor Payments Data

Brian Karamian

Orthopaedic Surgery of the Spine · Palo Alto, CANPI 1629465182

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 30.4% of the total. 2025 is the largest year on record at $12,288, 5.2 times the $2,368 reported in 2019.

$24,903in general payments, 2019–2025

Across 73 payments — averaging $341.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$8K
  • Kuros Biosciences USA, Inc$8K
  • Synthes GmbH$3K
  • Evolution Surgical, Inc$2K
  • Globus Medical$2K
  • Medical Device Business Services, Inc.$930
  • plus $2K from 8 others

What the payments were for

  • Consulting fees$12,36050%
  • Speaking & faculty fees$1,5006%
  • Travel & lodging$5,46322%
  • Food & beverage$3,21213%
  • Education$2,36810%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,903 in reported general payments places this provider in the 55th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California →

Medicare billing

Part B allowed, 2024
$213,750
Medicare patients
134
Services billed
661

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery of the spine in Palo Alto

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →